Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022

Background: The efficacy and safety of Janus kinase (JAK) inhibitors as novel therapeutic agents for psoriasis (PSO) and psoriatic arthritis (PsA) have not yet been systematically evaluated. Methods: Randomized controlled studies (RCTs) assessing JAK inhibitors to treat PSO or PsA published before S...

全面介紹

書目詳細資料

發表在:	Heliyon
Main Authors:	Jiao Wang, Tian Ma, Xiaoying Sun, Liu Liu, Seokgyeong Hong, Huijung Cha, Miao Zhang, Jiale Chen, Naixuan Lin, Bin Li, Xin Li
格式:	Article
語言:	英语
出版:	Elsevier 2025-02-01
主題:	Janus kinase (JAK) inhibitors Psoriasis (PSO) Psoriatic arthritis (PsA) Randomized controlled study Meta-analysis
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2405844025004645